Roles of sensitization to staphylococcus enterotoxin in patients with obstructive lung diseases

C. Morimoto (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), S. Sato (Kyoto, Japan), T. Oguma (Kyoto, Japan), A. Sato (Kyoto, Japan), N. Tashima (Kyoto, Japan), Y. Ishiyama (Kyoto, Japan), H. Sunadome (Kyoto, Japan), T. Nagasaki (Kyoto, Japan), I. Ito (Kyoto, Japan), S. Muro (Kashihara, Japan), T. Hirai (Kyoto, Japan)

Source: International Congress 2019 – Clinical aspects of airway diseases
Session: Clinical aspects of airway diseases
Session type: Thematic Poster
Number: 2762
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Morimoto (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), S. Sato (Kyoto, Japan), T. Oguma (Kyoto, Japan), A. Sato (Kyoto, Japan), N. Tashima (Kyoto, Japan), Y. Ishiyama (Kyoto, Japan), H. Sunadome (Kyoto, Japan), T. Nagasaki (Kyoto, Japan), I. Ito (Kyoto, Japan), S. Muro (Kashihara, Japan), T. Hirai (Kyoto, Japan). Roles of sensitization to staphylococcus enterotoxin in patients with obstructive lung diseases. 2762

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Roles of sensitization to Staphylococcal enterotoxin in patients with bronchiectasis
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: 240-244
Year: 2007



Bacterial bronchopulmonary infection-induced exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002

Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Are antibiotics useful in acute exacerbations of chronic bronchitis?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=189
Year: 2004

Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa: resistance to common antibiotics
Source: Eur Respir J 2001; 18: Suppl. 33, 540s
Year: 2001

Impact of Pseudomonas aeruginosa on exacerbation and death in patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004

Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Year: 2017



Risk factors for MRSA staphylococcal carriage in children with chronic allergic diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 265s
Year: 2006

Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients
Source: ERJ Open Res, 6 (4) 00265-2020; 10.1183/23120541.00265-2020
Year: 2020



Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014


Impacts on Mycoplasma pneumoniae infection in acute exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 337s
Year: 2003

Mucus production in chronic obstructive lung diseases: relationship with infections
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006


Analysis of pathogenic secretory immunity factors in saliva from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Year: 2007


Pathogenic therapy of patients with chronic obstructive pulmonary diseases (COPD)
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007


Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence?
Source: Eur Respir J 2002; 19: 387-389
Year: 2002


The role of chlamydia pneumoniae infection in acute purulent exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 221s
Year: 2002

Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010